Q1: Subsequent Transplant or Cellular Therapy

Question 1: Is this the report of a second or subsequent transplant or cellular therapy for the same disease?

Report No and go to Specify the leukodystrophy question in any of the following scenarios:

• This is the first infusion reported to the CIBMTR; or
• This is a second or subsequent infusion for a different disease (i.e., the patient was previously transplanted for a disease other than a leukodystrophy); or
• This is a second or subsequent infusion for the same disease subtype and this baseline disease insert was not completed for the previous transplant (i.e., the patient was on the TED track for the prior infusion, prior infusion was autologous with no consent, etc.).

Report Yes and go to the Clinical Status Prior to Preparative Regimen section if this is a subsequent infusion for the same disease and the baseline Leukodystrophies disease form was completed previously.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.		.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.